BACHEM HOLDING AG
F:BHM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
BACHEM HOLDING AG (BHM) under the Base Case is 7.72 EUR per share.
Compared with the current market price of 10.2 EUR, the stock appears
Overvalued by 24% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What BACHEM Does
Bachem Holding AG makes custom peptide and oligonucleotide ingredients for the pharmaceutical industry. In plain English, it helps drug makers design and produce hard-to-make molecules that often become the active part of medicines, especially in areas like diabetes, cancer, and rare diseases. Its customers are mainly big drug companies and biotech firms that need a specialist partner to develop and manufacture these compounds under strict quality rules.
- Headquarters
- Switzerland CH
- Employees
- 2 511
- IPO date
- Jun 29, 2001
Continue BHM Research
Decided on BACHEM HOLDING? Get an email when BHM reaches the price you’d buy at. Free with an account.
Other BACHEM HOLDING listings
What is the Intrinsic Value of one BHM stock?
The intrinsic value for
BACHEM HOLDING AG (BHM) under the Base Case is 7.72 EUR.
Is BHM stock undervalued or overvalued?
Compared with the current market price of 10.2 EUR, the stock appears Overvalued by 24% .